Niagen Bioscience, Inc. NAGE

NAGE Company Overview

Niagen Bioscience, Inc. (NASDAQ: NAGE) is a biotechnology and nutraceutical company focused on healthy aging, cellular metabolism, and nicotinamide adenine dinucleotide (NAD+) science. The company develops and commercializes ingredients, consumer products, and intellectual property related primarily to nicotinamide riboside (NR), a precursor to NAD+, which is involved in cellular energy production and metabolic function. The company operates within the dietary supplements, bioscience, and longevity-focused health sectors, with activities spanning scientific research, ingredient commercialization, and consumer wellness products.

The company’s primary revenue drivers include sales of its patented nicotinamide riboside ingredient branded as Niagen®, direct-to-consumer supplement products marketed under Tru Niagen®, and licensing or business-to-business supply agreements with commercial partners. Niagen Bioscience serves consumers interested in healthy aging, cognitive health, metabolic wellness, and cellular health, while also supplying ingredient solutions to manufacturers and health-product companies. Originally founded in 1999 as ChromaDex Corporation, the company evolved from an analytical standards and ingredient verification business into a bioscience-focused enterprise centered on NAD+ research and commercialization. The company formally rebranded to Niagen Bioscience to align more directly with its flagship ingredient and longevity-science strategy.